PharmTech
CONTINUE TO SITE >

OR WAIT 15 SECS

Pharmaceutical Technology
Spotlight
COVID-19 UpdateAnalyticsDrug DevelopmentManufacturingOutsourcingQuality Systems2020 Bio/Pharma Virtual Congress
Topic
View MoreAnalytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDosage FormsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain
News
All NewsTop NewsIndustry NewsBio/Pharma NewsSupplier NewsNews from EuropeEvents
Publications
All PublicationsPharmTechPharmTech Europe
Resources
Front & CenterPharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers
WebcastsMarketplace
Subscribe
EnewslettersMagazine North AmericaMagazine Europe

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Contacts
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.

Spotlight
  • COVID-19 Update
  • Analytics
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
  • 2020 Bio/Pharma Virtual Congress
TopicSee All >
  • Analytical Method Development
  • APIs
  • Aseptic Processing
  • Biologic Drugs
  • Dosage Forms
  • Drug Delivery
  • Equipment
  • Excipients
  • Formulation
  • Packaging
  • Process Control/PAT
  • Process Development
  • QA/QC
  • Regulatory Action
  • Supply Chain
  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Contacts
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.

Patheon to Acquire Banner Pharmacaps

October 31, 2012
Stephanie Sutton
Stephanie Sutton

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Patheon will acquire softgel-specialist company Banner Pharmacaps, based in North Carolina in the US, for $255 million

Patheon will acquire softgel-specialist company Banner Pharmacaps, based in North Carolina in the US, for $255 million. The acquisition will provide Patheon with several new products, technologies and facilities, and is also in line with the company’s intention to further develop its oral dosage development and manufacturing services.

According to a press statement, Banner Pharmacaps is the second largest pharmaceutical business in the world focused on developing softgel formulations. The company has research laboratories and manufacturing facilities in the US, the Netherlands, Canada and Mexico.

James C. Mullen, CEO of Patheon, said in the statement, “The transaction provides is with a well-balanced portfolio of proprietary products, state-of-the-art facilities with enhanced capabilities, as well as an expanded geographical presence. We believe our visibility with in the industry will be further strengthened as we pass the $1-billion revenue mark.”

Patheon is purchasing Banner Pharmacaps from VION N.V., a manufacturer of foodstuffs and ingredients based in the Netherlands. VION intends to now focus on its core business in the food industry.

The acquisition is expected to close by the end of this year.